Finance

Lists
Outlook: 23.3% bullish·7.0% bearish
Go to analysis
MRK:NYSE
မာ့ခ်
၁၄၅.၁၉ US$
-၁.၄၈%
(-၂.၁၈) 1D
၁၄၅.၂၀ US$
+၀.၀၁% (+၀.၀၁၀၀)
After hours
Closed: အောက် ၁၅, GMT-၄ ၁၆:၀၄:၄၃  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MRK...
Open
၁၄၉.၇၀ US$
High
၁၅၂.၃၄ US$
Low
၁၄၄.၉၁ US$
Mkt. cap
ဋေ ၃.၅၈ သ
Avg. vol.
၉.၃၃ သန်း
Volume
၁.၃၉ ကုဋေ
Dividend
၂.၃၄%
Quarterly dividend
၀.၈၅ US$
Ex-dividend date
၂၀၂၆ စက် ၁၅
P/E ratio
၁၁၅.၉၆
52-wk high
၁၅၆.၉၂ US$
52-wk low
၈၂.၀၁ US$
EPS
၁.၂၅ US$
Beta
၀.၂၁
Shares outstanding
၂၄၆.၇၂ ဋေ
No. of employees
၇ သောင်း
Open
၁၄၉.၇၀ US$
High
၁၅၂.၃၄ US$
Low
၁၄၄.၉၁ US$
Mkt. cap
ဋေ ၃.၅၈ သ
Avg. vol.
၉.၃၃ သန်း
Volume
၁.၃၉ ကုဋေ
Dividend
၂.၃၄%
Quarterly dividend
၀.၈၅ US$
Ex-dividend date
၂၀၂၆ စက် ၁၅
P/E ratio
၁၁၅.၉၆
52-wk high
၁၅၆.၉၂ US$
52-wk low
၈၂.၀၁ US$
EPS
၁.၂၅ US$
Beta
၀.၂၁
Shares outstanding
၂၄၆.၇၂ ဋေ
No. of employees
၇ သောင်း
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၃ နာရီ
Merck (MRK) Adds A Board Veteran, Is It Still 5% Below Fair Value?
News Corp
News Corp
·
ပြီးခဲ့သည့် ၄ နာရီ
AI Stocks Are Hurting. Look at These Other Sectors for Protection.
Benzinga
Benzinga
·
ပြီးခဲ့သည့် ၅ နာရီ
Nike, Moderna, Walmart Get a Lift as Traders Flee AI Stocks
Profile
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
About မာ့ခ်
CEORobert M Davis
Employees၇.၄ သောင်း
Founded၁၈၉၁ ဇန် ၁
Headquarters-
Sector-
Websitemerck.com
Analyst ratings
Based on 21 analysts giving stock ratings to MRK in the past 3 months
Buy
Buy
15
Hold
6
Sell
0
12-month forecast
Based on 21 Wall Street analysts offering 12 month price targets for MRK in the last 3 months.
Highest
Current ၁၄၅.၁၉ US$
၁၈၀.၀၀ US$ (+၂၃.၉၈%)
Average
၁၆၀.၀၀ US$ (+၁၀.၂၀%)
Lowest
၁၀၅.၀၀ US$ (-၂၇.၆၈%)
Analyst
Recommendation
Action
Price target
Projected
Date
Mohit Bansal
Wells Fargo
Buy
Maintained
၁၆၅.၀၀ US$
+၁၃.၆%
10/15/2026
Evan Seigerman
BMO Capital
Buy
Maintained
၁၇၀.၀၀ US$
+၁၇.၁%
10/12/2026
Carter Gould
Cantor Fitzgerald
Hold
Maintained
၁၄၅.၀၀ US$
-၀.၁%
10/11/2026
Daina Graybosch
Leerink Partners
Buy
Maintained
၁၆၁.၀၀ US$
+၁၀.၉%
10/12/2026
Trung Huynh
RBC Capital
Hold
Reiterated
၁၄၅.၀၀ US$
-၀.၁%
10/12/2026
Geoff Meacham
Citi
Hold
Maintained
၁၄၅.၀၀ US$
-၀.၁%
10/13/2026
Emily Field
Barclays
Buy
Maintained
၁၅၀.၀၀ US$
+၃.၃%
10/12/2026
Michael Yee
UBS
Buy
Maintained
၁၇၅.၀၀ US$
+၂၀.၅%
10/09/2026
Jason Gerberry
Bank of America Securities
Buy
Maintained
၁၆၃.၀၀ US$
+၁၂.၃%
10/09/2026
Terence Flynn
Morgan Stanley
Buy
Maintained
၁၇၇.၀၀ US$
+၂၁.၉%
10/07/2026
Chris Schott
J.P. Morgan
Buy
Maintained
၁၆၅.၀၀ US$
+၁၃.၆%
10/05/2026
Asad Haider
Goldman Sachs
Buy
Maintained
၁၆၀.၀၀ US$
+၁၀.၂%
09/30/2026
Louise Chen
Scotiabank
Buy
Maintained
၁၈၀.၀၀ US$
+၂၄%
09/29/2026
Steve Scala
TD Cowen
Hold
Maintained
၁၅၅.၀၀ US$
+၆.၈%
09/22/2026
Nico Chen
DBS
Buy
Maintained
၁၈၀.၀၀ US$
+၂၄%
09/11/2026
Rajesh Kumar
HSBC
Buy
Maintained
၁၇၂.၀၀ US$
+၁၈.၅%
09/10/2026
Vamil Divan
Guggenheim
Buy
Reiterated
၁၇၀.၀၀ US$
+၁၇.၁%
09/08/2026
Courtney Breen
Bernstein
Hold
Maintained
၁၀၅.၀၀ US$
-၂၇.၇%
09/07/2026
Jasper Hellweg
Argus Research
Buy
Reiterated
၁၇၀.၀၀ US$
+၁၇.၁%
08/24/2026
Alexandria Hammond
Wolfe Research
Buy
Maintained
၁၈၀.၀၀ US$
+၂၄%
08/25/2026
Luisa Hector
Berenberg Bank
Hold
Maintained
၁၂၇.၀၀ US$
-၁၂.၅%
08/05/2026
Unknown Analyst
Jefferies
Buy
Maintained
၁၃၈.၀၀ US$
-၅%
05/19/2026
Unknown Analyst
Argus Research
Buy
Reiterated
၁၃၀.၀၀ US$
-၁၀.၅%
05/08/2026
Hans Engel
Erste Group
Hold
Maintained
-
-
05/05/2026
Natalya Davies
Rothschild & Co Redburn
Buy
Maintained
၁၇၉.၀၀ US$
+၂၃.၃%
04/17/2026
James Shin
Deutsche Bank
Buy
Upgraded
၁၅၀.၀၀ US$
+၃.၃%
02/13/2026
Next call ၁၄ ရက်အတွင်း
အောက် ၂၉ ကြာသပတေး, ၁၅:၀၀
Fiscal period
Q3 2026
- / ၂.၀၉ US$
Revenue / Est. (USD)
- / ဋေ ၁.၇၃ ထ
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
ဋေ ၁.၇၃ ထ
ဋေ ၁.၆၄ ထ
ဋေ ၁.၆၃ ထ
ဋေ ၁.၆၆ ထ
Cost of goods sold
၃၇၄.၅၀ ဋေ
၄၂၉.၅၀ ဋေ
၃၈၇.၅၀ ဋေ
၄၁၂.၈၀ ဋေ
Cost of revenue
၃၇၄.၅၀ ဋေ
၄၂၉.၅၀ ဋေ
၃၈၇.၅၀ ဋေ
၄၁၂.၈၀ ဋေ
Research and development expenses
၄၀၀.၁၀ ဋေ
၃၉၉.၇၀ ဋေ
၃၅၅.၈၀ ဋေ
၉၇၄.၂၀ ဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၂၄၈.၁၀ ဋေ
၂၇၃.၃၀ ဋေ
၂၅၆.၆၀ ဋေ
၂၇၇.၇၀ ဋေ
Operating expense
၆၄၈.၂၀ ဋေ
၆၇၃.၀၀ ဋေ
၆၁၂.၄၀ ဋေ
ဋေ ၁.၂၅ ထ
Total operating expenses
ဋေ ၁.၀၂ ထ
ဋေ ၁.၁၀ ထ
၉၉၉.၉၀ ဋေ
ဋေ ၁.၆၆ ထ
Operating income
၇၀၄.၉၀ ဋေ
၅၃၇.၅၀ ဋေ
၆၂၈.၇၀ ဋေ
-၄.၀၀ ကုဋေ
Other non operating income
-
၄.၁၀ ကုဋေ
၄.၂၀ ကုဋေ
၅.၉၀ ကုဋေ
EBT including unusual items
၆၇၄.၅၀ ဋေ
၃၄၂.၀၀ ဋေ
-၃၅၃.၄၀ ဋေ
-၆၈.၃၀ ကုဋေ
EBT excluding unusual items
၆၇၆.၂၀ ဋေ
၄၉၇.၅၀ ဋေ
၅၈၄.၇၀ ဋေ
-၅၀.၈၀ ကုဋေ
Income tax expense
၉၅.၈၀ ကုဋေ
၄၅.၈၀ ကုဋေ
၇၀.၉၀ ကုဋေ
၆၅.၄၀ ကုဋေ
Effective tax rate
၁၄.၂၀%
၁၃.၃၉%
-၂၀.၀၆%
-၉၅.၇၅%
Other operating expenses
-
-
-
-
Net income
၅၇၈.၅၀ ဋေ
၂၉၆.၃၀ ဋေ
-၄၂၄.၀၀ ဋေ
-၁၃၃.၅၀ ဋေ
Net profit margin
၃၃.၄၉%
၁၈.၀၇%
-၂၆.၀၃%
-၈.၀၄%
Earnings per share
၂.၅၈
၂.၀၄
-၁.၂၈
-၀.၁၃
Interest and investment income
၉.၆၀ ကုဋေ
၆.၉၀ ကုဋေ
၃.၅၀ ကုဋေ
၃.၅၀ ကုဋေ
Interest expense
-၃၂.၇၀ ကုဋေ
-၄၁.၁၀ ကုဋေ
-၄၇.၉၀ ကုဋေ
-၅၂.၅၀ ကုဋေ
Net interest expenses
-၂၃.၁၀ ကုဋေ
-၃၄.၂၀ ကုဋေ
-၄၄.၄၀ ကုဋေ
-၄၉.၀၀ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၈၁၄.၇၀ ဋေ
၆၇၉.၃၀ ဋေ
၇၆၉.၁၀ ဋေ
၁၄၂.၈၀ ဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ